Stress and pain responses in rats lacking CCK1 receptors

Peptides

Volumn 27, Issue 6, 2006, Pages 1483-1489

  Hurwitz, I ^a   Malkesman, O ^a   Stern, Y ^a   Schroeder, M ^a   Lavi Avnon, Y ^a   Shayit, M ^a   Shavit, Y ^b   Wolf, G ^b   Yirmiya, R ^b   Weller, A ^a  

^a BAR ILAN UNIVERSITY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Anxiety; CCK; Natural preference; OLETF rats; Pain; USV

Indexed keywords

CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; DEVAZEPIDE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG MECHANISM; ECHOGRAPHY; FEMALE; HOT PLATE TEST; MALE; NONHUMAN; OLFACTORY DISCRIMINATION; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; STRESS; TACTILE DISCRIMINATION; VOCALIZATION;

AGING; ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; FEMALE; MALE; ODORS; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RECEPTORS, CHOLECYSTOKININ; STRESS; TIME FACTORS;

EID: 33646764159     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2005.10.009     Document Type: Article

References (47)

1. Barbaz B.S., Hall N.R., and Liebman J.M. Antagonism of morphine analgesia by CCK-8-S does not extend to all assays nor all opiate analgesics. Peptides 9 (1989) 1295-1300
2. Bi S., Ladenheim E.E., Schwartz G.J., and Moran T.H. A role for NPY overexpression in the dorsomedial hypothalamus in hyperphagia and obesity of OLETF rats. Am J Physiol 281 (2001) R254-R260
3. Blass E.M., and Fitzgerald E. Milk-induced analgesia and comforting in 10-days-old rats: opioid mediation. Pharmacol Biochem Behav 29 (1988) 9-13
4. Blass E.M., and Shide D.J. Endogenous cholecystokinin reduces vocalization in isolated 10-days-old rats. Behav Neurosci 107 (1993) 488-492
5. 1 receptors. Am J Physiol 2005, in press.
6. Brunelli S.A.B., and Hofer M.A. Selective breeding for an infantile phenotype (isolation calling): a window on developmental forces. In: Blass E.M. (Ed). Handbook of behavioral neurobiology vol. 13 (2001), Plenum Press, New York 433-482
7. Crawley J.N., and Corwin R.L. Biological actions of cholecystokinin. Peptides 15 (1994) 731-735
8. Dauge V., Bohme G.A., Crawley J.N., Durieux C., Stutzmann J.M., Feger J., et al. Investigation of behavioral and electrophysiological responses induced by selective stimulation of CCK-B receptor by using a new highly potent CCK analog, BC264. Synapse 6 (1990) 73-80
9. Dockray G.J. Immunochemical evidence of choolecystokinin-like peptides in brain. Nature 264 (1976) 568-570
10. Dourish C.T., Hawley D., and Iversen S.D. Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718. Eur J Pharmacol 147 (1988) 469-472
11. Funakoshi A., Miyassaka K., Shinozaki H., Masuda M., Kawanami T., Takata Y., et al. An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor. Biochem Biophys Res Commun 210 (1995) 787-796
12. A receptors. Eur J Pharmacol 209 (1991) 263-266
13. Hofer M.A. Multiple regulators of ultrasonic vocalization in the infant rat. Psychoneuroendocrinology 21 (1996) 203-217
14. Hokfelt T., Holmberg K., Shi T.J., and Broberger C. CCK-ergic mechanisms in sensory systems. Scand J Clin Lab Invest Suppl 234 (2001) 69-74
15. Huhtala V., Lehtonen L., Uvnas-Moberg K., and Korvenranta H. Low plasma cholecystokinin levels in colicky infants. J Pediatr Gastroenterol Nutr 37 (2003) 42-46
16. Insel T.R., and Winslow J.T. Rat pup ultrasonic vocalizations: an ethologically relevant behavior responsive to anxiolytics. In: Olivier B., Mos J., and Slangen J.L. (Eds). Animal models in psychopharmacology (1991), Birkhauser-Verlag, Basel 15-36
17. Kawano K.T., Hirashima S., Mori S., Saitoh Y., Kurosumi M., and Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications: Otsuka Long Evans Tokushima Fatty (OLETF) strain. Diabetes 41 (1992) 1422-1428
18. Kraebel K.S., Brasser S.M., Campbell J.O., Spear L.P., and Spear N.E. Developmental differences in temporal patterns and potentiation of isolation-induced ultrasonic vocalizations: Influence of temperature variables. Dev Psychobiol 40 (2002) 147-159
19. A receptors. Behav Neurosci 118 (2004) 282-289
20. Lavigne G.J., Millington W.R., and Mueller G.P. The CCK-A and CCK-B receptor antagonists, devazepide and L-365,260, enhance morphine antinociception only in non-acclimated rats exposed to a novel environment. Neuropeptides 21 (1992) 119-129
21. Lee G.S., Han J.B., Shin M.K., Hong M.C., Kim S.W., Min B.I., et al. Enhancement of electroacupuncture-induced analgesic effect in cholecystokinin-A receptor deficient rats. Brain Res Bull 62 (2003) 161-164
22. Li X.-L., Aou S., Hori T., and Oomura Y. Spatial memory deficit and emotional abnormality in OLETF rats. Physiol Behav 75 (2002) 15-23
23. Miyasaka K., Kobayashi S., Ohta M., Kanai S., Yoshida Y., Nagata A., et al. Anxiety-related behaviors in cholecystokinin-A, B, and AB receptor gene knockout mice in the plus-maze. Neurosci Lett 335 (2002) 115-118
24. Moran T.H., Katz L.F., Plata-Salaman C.R., and Schwartz G.J. Disordered food intake and obesity in rats lacking cholecystokinin A receptors. Am J Physiol 274 (1998) R618-R625
25. Moran T.H., Robinson P.H., Goldrich M.S., and McHugh P.R. Two brain cholecystokinin receptors: implications for behavioral actions. Brain Res 362 (1986) 175-179
26. Nakamura H., Kihara Y., Tashiro M., Kanagawa K., Shirohara H., Yamamoto M., et al. Defects of cholecystokinin (CCK)-A receptor gene expression and CCK-A receptor-mediated biological functions in Otsuka Long Evans Tokushima Fatty (OLETF) rats. J Gastroenterol 33 (1998) 702-709
27. 2 receptors in the homeostasis of the opioid system. Drugs Today (Barc) 39 (2003) 897-908
28. Nomoto S., Miyake M., Ohta M., Funakoshi A., and Miyasaka K. Impaired learning and memory in OLETF rats without cholecystokinin (CCK)-A receptor. Physiol Behav 66 (1999) 869-872
29. Olivier B., Molewijk H.E., van der Heyden J.A.M., van Oorschot R., Mos J., and Miczek K.A. Ultrasonic vocalizations in rat pups: Effects of serotonergic ligands. Neurosci Biobehav Rev 23 (1998) 215-227
30. Rastegar H., Homayoun H., Afifi M., Rezayat M., and Dehpour A.R. Modulation of cholestasis-induced antinociception by CCK receptor agonists and antagonists. Eur Neuropsychopharmacol 12 (2002) 111-118
31. Rex A., Barth T., Voigt J.-P., Domeney A.M., and Fink H. Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety. Neurosci Lett 172 (1994) 139-142
32. Rakover-Atar S., and Weller A. The influence of natural preference for tactile stimuli on appetitive learning in rat pups. Dev Psychobiol 30 (1997) 29-39
33. Sei M., Sei H., and Shima K. Spontaneous activity, sleep, and body temperature in rats lacking the CCK-A receptor. Physiol Behav 68 (1999) 25-29
34. Shayit M., and Weller A. Cholecystokinin receptor antagonists increase the rat pup's preference towards maternal-odor and rug texture. Dev Psychobiol 38 (2001) 164-173
35. Suh H.W., Kim Y.H., Choi Y.S., and Song D.K. Involvement of different subtypes of cholecystokinin receptors in opioid antinociception in the mouse. Peptides 16 (1995) 1229-1234
36. Takiguchi S., Takata Y., Funakoshi A., Miyasaka K., Kataoka K., Fujimura Y., et al. Disrupted cholecystokinin type-A receptor (CCKAR) gene in OLETF rats. Gene 197 (1997) 169-175
37. Tortorici V., Nogueira L., Salas R., and Vanegas H. Involvement of local cholecystokinin in the tolerance induced by morphine microinjections into the periaqueductal gray of rats. Pain 102 (2003) 9-16
38. Wank S.A. G protein-coupled receptors in gastrointestinal physiology I. CCK receptors: an exemplary family. Am J Physiol 274 (1998) G607-G613
39. Wank S.A., Pisegna J.R., and De Weerth A. Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression. Proc Natl Acad Sci USA 89 (1992) 3125-3129
40. Watkins L.R., Kinscheneck I.B., Kaufman E.F.C., Miller J., Frenk H., and Mayer D.J. Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates. Brain Res 327 (1985) 181-190
41. Weller A. The ontogeny of motivation: Hedonic preferences and their biological basis in developing rats. In: Blass E.M. (Ed). Handbook of Behavioral Neurobiology vol. 13 (2001), Plenum Press, New York 483-516
42. Weller A., and Blass E.M. Behavioral evidence for cholecystokinin-opiate interactions in neonatal rats. Am J Physiol 255 (1988) R901-R907
43. Weller A., and Gispan I.H. A cholecystokinin receptor antagonist blocks milk-induced but not maternal-contact-induced decrease in ultrasonic vocalization in rat pups. Dev Psychobiol 37 (2000) 35-43
44. Weller A., Tsitolovskya L., Gispan I.H., and Rabinowitz S. Examining the role of cholecystokinin in appetitive learning in the infant rat. Peptides 22 (2001) 1317-1323
45. Wolf G., Yirmiya R., Goshen I., Iverfeldt K., Holmlund L., Takeda K., et al. Impairment of interleukin-1 (IL-1) signaling reduces basal pain sensitivity in mice: genetic, pharmacological and developmental aspects. Pain 104 (2003) 471-480
46. Xie J.Y., Herman D.S., Stiller C.O., Gardell L.R., Ossipov M.H., Lai J., et al. Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance. J Neurosci 25 (2005) 409-416
47. Yamamoto Y., Akiyoshi J., Kiyota A., Katsuragi S., Tsutsumi T., Isogawa K., et al. Increased anxiety behavior in OLETF rats without cholecystokinin-A receptor. Brain Res Bull 53 (2000) 789-792